PLANETS
teamLab Planets TOKYO DMM in Toyosu, Tokyo (hereinafter referred to as teamLab Planets), welcomed a total of 2,504,264 visitors from April 1, 2023, to March 31, 2024. This accomplishment has earned it recognition by GUINNESS WORLD RECORDS as the most visited museum (single art group) in the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240709556561/en/
teamLab Planets in Tokyo has been recognized by GUINNESS WORLD RECORDS™ as the most visited museum (single art group) in the world.(teamLab, Highlight video of teamLab Planets, Toyosu, Tokyo / Video: teamLab)
Additionally, teamLab Planets recorded a total of 2,412,495 visitors from January to December 2023 (*1). When compared to "The Art Newspaper Visitor Figures 2023" survey (*2), which compares visitor numbers at museums around the world, teamLab Planets significantly surpassed other single-artist museums, such as the Van Gogh Museum in Amsterdam (1,686,766 visitors) and the Picasso Museum in Barcelona (1,047,094 visitors).
teamLab Planets also ranked 5th in Google's "Year in Search 2023" for the "Most Popular Museums in the World" (*3), following the Louvre Museum (Paris), the British Museum (London), Musée d'Orsay (Paris), and the Natural History Museum (London).
This recognition marks the second GUINNESS WORLD RECORDS title for a teamLab museum, following the 2019 record set by teamLab Borderless: MORI Building DIGITAL ART MUSEUM in Odaiba, Tokyo, which attracted 2,198,284 visitors (*4).
MASSIVE NEW AREA TO OPEN IN EARLY 2025
In early 2025, teamLab Planets will expand significantly with the addition of major new art spaces. The new area will feature the creative athletic space Athletics Forest, the co-creative educational project Future Park, as well as the Catching and Collecting Forest. The expansion will include over 10 art installations, greatly enhancing the teamLab Planets experience.
ATHLETICS FOREST
Athletics Forest is a creative athletic space based on the concept of understanding the world through the body and thinking about the world three-dimensionally. People immerse their entire body in the complex and physically challenging three-dimensional space of the interactive world.
"Humans perceive the world with their bodies and think with their bodies. When you explore a complex, three-dimensional world with your own body, you physically perceive the world three-dimensionally and in turn your thoughts become three-dimensional. We started this project, Athletics Forest, with the hopes to enhance three-dimensional and higher-dimensional thinking.
Spatial awareness is said to be correlated with innovation and creativity. I grew up in a rural area and played in the mountains, but in today's society and schools, the body is stationary. I think cities are surrounded too much by flat information such as books, TV, and smartphone screens. That is why we created a three-dimensional space that excessively demands the physical body. It is a space where people can perceive art with their physical bodies."
- teamLab Founder, Toshiyuki Inoko
Read more about the Athletics Forest concept:
https://www.teamlab.art/concept/athletics-forest/
FUTURE PARK
Future Park is an educational project based on the concept of collaborative creation (co-creation). It is an amusement park where people can enjoy creating the world freely with others.
An artwork comes to life through the process of people creating something together with others. As people continue to co-create, the artwork evolves endlessly.
Read more about the Future Park concept: https://www.teamlab.art/concept/future-park/
CATCHING AND COLLECTING FOREST
Catching and Collecting Forest is a new learning space based on the concept of Catch, Study, Release, in which people explore the world with their bodies, discovering, catching, and broadening their interests based on what they catch. Visitors explore with their smartphones, capture various creatures, study them, and create their very own collection book.
When a visitor uses the smartphone's camera to look at an animal moving in the space and shoots a Study Arrow at the animal in the camera's view, the arrow flies out from the phone into the real space. When the Study Arrow reaches the animal, it disappears from the space and is added to the visitor’s own smartphone collection. When a visitor swipes a captured animal towards a location seen in the app's camera, the animal is released and returns to that location.
"Physically exploring with others, discovering and catching something, then taking the chance to broaden interests based on what was caught. This is what we have been doing naturally over the long course of human history.
For humanity, the acts of catching and gathering are fun, educational, and part of life."
- teamLab Founder, Toshiyuki Inoko
Read more about the Catching and Collecting Forest concept:
https://www.teamlab.art/concept/catching/
About teamLab Planets
In Google’s "Year in Search 2023" annual search ranking, teamLab Planets ranked in the top 5 for "Most Popular Museums in the World" (*3). Amidst global museums with over a century of history, teamLab Planets is the sole museum from Japan to make the list. Additionally, it was named the most popular tourist attraction in Tokyo for two consecutive years by Honichi Lab (Visit Japan Lab)'s "Ranking of Popular Tourist Attractions Among Foreign Visitors: Tokyo Edition" (*5), chosen from a total of 2,662 attractions in Tokyo.
Furthermore, teamLab Planets has garnered international acclaim, including being the first in Japan to win "Asia's Leading Tourist Attraction 2023" at the World Travel Awards, often referred to as the Oscars of the travel industry.
teamLab Planets Concept
Together with Others, Immerse your Entire Body, Perceive with your Body, and Become One with the World
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. It comprises 4 large-scale artwork spaces and 2 gardens created by art collective teamLab.
People go barefoot and immerse their entire bodies in the vast artworks together with others. The artworks change under the presence of people, blurring the perception of boundaries between the self and the works. Other people also create change in the artworks, blurring the boundaries between themselves and the works, and creating a continuity between the self, the art, and others.
Official website: teamlab.art.planets
Visitor Information
teamLab Planets TOKYO DMM
Toyosu, Tokyo (6-1-16 Toyosu, Koto-ku, Tokyo)
https://maps.app.goo.gl/QVs4a34HD9qnvjUo8
Hours: Daily 9:00 - 22:00
Closed: Wednesday, August 7; Wednesday, September 4
*Last entry one hour before closing.
*Hours are subject to change.
*Please check the official website for ticket prices.
teamLab Planets TOKYO DMM Ticket Store
https://teamlabplanets.dmm.com
Press Kit
https://www.dropbox.com/sh/ir7d2aui794eo6z/AAChbzX5wPsQm8cgkQ2ViFD4a?dl=0
*1. Based on teamLab Planets ticket user data (January 1, 2023 – December 31, 2023). |
*2. The Art Newspaper (2024) 'Visitor Figures 2023: The 100 most popular art museums in the world—blockbusters, bots and bounce-backs'. The Art Newspaper, 26 March. Available at:
|
*3 “artnet (2023) 'These Were the Most Popular Museums in the World, According to Google’s "Year in Search"'. artnet, 20 December. Available at:
|
*4 Press release on the world record for visitor numbers. Available at:
|
*5 Honichi Lab (2024) 'The Most Popular Tourist Spots in Tokyo Among Foreign Visitors in 2024: Asakusa Temple Ranks 3rd, and 1st Place is?'. Honichi Lab, 21 May. Available at:
|
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709556561/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release
Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe7.1.2026 08:30:00 CET | Press release
Exclusive agreement covers 13 Central and Eastern European markets Collaboration will help expand access to VANFLYTA for patients with newly diagnosed FLT3-ITD positive AML Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnose
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
